Dr. Annette P Bohannon, EDD Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3368 Highway 280, Suite G18, Alexander City, AL 35010 Phone: 256-329-3399 Fax: 256-329-3344 |
Megan Boatner Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1107 Cherokee Rd, Alexander City, AL 35010 Phone: 334-415-0821 |
Sarah Ann Flint, M.ED., LPC, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1120 Airport Dr Ste 201, Alexander City, AL 35010 Phone: 817-304-1404 |
Ms. Margaret Anne Barnes, M.ED., LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 393 Green St, Alexander City, AL 35010 Phone: 256-625-9514 |
Virginia Bradshaw Archer, L.P.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 216 Madison St, Alexander City, AL 35010 Phone: 256-487-2115 |
Dr. Kathie Irene Roper-ericson, PH.D Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 500 Lee St., The Greenhouse, Alexander City, AL 35011 Phone: 256-500-4187 Fax: 256-234-7517 |
Mary Heather Dixon Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1107 Cherokee Rd, Alexander City, AL 35010 Phone: 256-279-5869 |
Kimberly Dixon Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1107 Cherokee Rd, Alexander City, AL 35010 Phone: 256-279-5869 |
News Archive
For the first time, researchers have found a particular kind of molecular switch in the food poisoning bacteria Salmonella Typhimurium under infection-like conditions. This switch, using a process called S-thiolation, appears to be used by the bacteria to respond to changes in the environment during infection and might protect it from harm, researchers report this week online in the Proceedings of the National Academy of Sciences Early Edition.
Deworming children may not improve school attendance and the evidence that informs international policy needs to be re-appraised following a major re-analysis by researchers at the London School of Hygiene & Tropical Medicine.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
As leading figures in respiratory health from across the globe gather in Birmingham for the COPD8 conference ahead of World Spirometry Day, the European COPD Coalition (ECC) is calling on policy makers across Europe to recognise that chronic diseases such as COPD, present as great a threat as the global financial crisis, and is urging collective action.
› Verified 1 days ago